A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis

NCT00914290 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Spasticity
Multiple Sclerosis

Interventions

DRUG: IPX056
DRUG: Baclofen IR
DRUG: Placebo IPX056
DRUG: Placebo IR

Sponsor

Impax Laboratories, LLC